Published: April 25, 2025
After improving pediatric cancer survival from nearly nil in the 1950s to more than 85% today, health care providers face new challenges, especially long-term cognitive deficits associated with chemotherapy.
In addition to attacking cancer cells, chemotherapy also can affect healthy cells, including those in the central nervous system. This can lead to a range of cognitive impairments, often referred to as “chemobrain” or “chemofog.”
“As the population of childhood cancer survivors continues to grow, identifying and managing long-term effects, particularly cognitive deficits, grows in importance,” said Kerry K. McGowan, M.D., pediatric hematologist/oncologist with Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine.
“By adopting a multidisciplinary approach in partnership with primary care pediatricians, we can empower survivors to lead fulfilling lives beyond their cancer journey.”
More than 60% of pediatric cancer survivors experience at least one late effect, with a third having clinically significant events, including cognitive deficits that can significantly affect quality of life, academic performance and career prospects.
“A survey of childhood cancer survivors showed that they face problems,” Dr. McGowan said. “They are at risk to have learning disabilities or require support programs in school. A lot of these survivors, just by virtue of being in the hospital for extended periods, don’t get to form the regular social and parent interactions that they would normally have, and face problems reintegrating into school,” she said.
Early identification and intervention are crucial for mitigating the impact of cognitive deficits. This requires a multidisciplinary approach, involving:
To refer a patient to Norton Children’s Cancer Institute, visit NortonEpicCareLink.com and open an order for Pediatric Oncology.
Refer online
Call (502) 599-7337(PEDS)
To better address the challenges faced by pediatric cancer survivors, pediatric oncologists and others who treat these patients can pursue routine cognitive screenings for childhood cancer survivors, increased awareness among health care providers and additional research toward effective interventions for cognitive rehabilitation.